Search results
Added:
2 months ago
Navigate the complex landscape of coronary interventions following transcatheter aortic valve replacement with Dr Samineh Sehatbakhsh, addressing critical access challenges in an era of expanding TAVR indications.This essential presentation, part of the Complex Cases track, examines the growing clinical significance of post-TAVR coronary access as procedures expand to younger, lower-risk patients…
View more
Added:
5 months ago
EuroPCR 25 - Post-hoc anlysis outcomes from under-expansion of the ACURATE neo2 valve in severe aortic stenosis (AS) patients show under-expansion was associated with higher rates of death, stroke or rehospitalisation.We are joined by Dr Raj Makkar (Cedars-Sinai Heart Institute, Los Angeles, US) to discuss findings from the post-hoc analysis of the ACURATE IDE study (NCT03735667; Boston…
View more
Start date:
Nov 27, 2024
Added:
1 year ago
In this insightful interview, Dr Joanna J Wykrzykowska (University of Groningen, Groningen, NL), Prof Holger Thiele (Heart Center Leipzig at University of Leipzig, Leipzig, DE), and Prof Helge Möllmann (St Johannes Hospital, Dortmund, DE) discuss the findings and implications of the PROVE Registry, a comprehensive multi-centre all-comers study focused on the ACURATE neo2 transcatheter aortic…
View more
Added:
2 weeks ago
Source:
Radcliffe Cardiology
The optimal duration of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) requires a careful balance between reducing ischaemic events and minimising bleeding risk. The HOST-BR trial was designed to evaluate the ideal DAPT duration in patients stratified by their bleeding risk.¹This open-label, multicentre, randomised clinical trial enrolled 4,897 patients who…
View more
Added:
4 months ago
New York Valves 2025 - Echocardiographic outcomes from the TRISCEND II substudy reinforce the effectiveness of TTVR compared to medical therapy alone at one year post transcatheter tricuspid valve replacement (TTVR).Dr Paul Grayburn (Baylor Scott and White Research Institute, Dallas, US) joins us to discuss echocardiographic outcomes one year post TTVR from the TRISCEND II substudy which…
View more
Added:
4 months ago
Source:
Radcliffe Cardiology
AUTHOR: Ola WisniewskaA novel optical coherence tomography (OCT)-based physiological assessment, virtual flow reserve (VFR), has been shown to predict 2-year clinical outcomes following percutaneous coronary intervention (PCI), independent of anatomical measures like minimal stent area (MSA). This finding comes from a new substudy of the ILUMIEN IV trial, highlighting the potential of VFR to…
View more
ESC 23: The RIGHT Study
Added:
2 years ago
Video
Added:
2 months ago
Source:
Radcliffe Cardiology
Early withdrawal of aspirin in favour of potent P2Y12 inhibitor monotherapy following percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) did not meet the criteria for noninferiority regarding ischaemic events compared to standard dual antiplatelet therapy (DAPT), according to the results of the NEO-MINDSET trial.¹ The strategy did, however, demonstrate superiority in…
View more
Added:
6 months ago